sun pharma
Sun Pharma's Taro resolves multi-year investigations over generic drug pricing
Taro Pharmaceutical said that it is discussing a separate corporate integrity agreement with the department of health and human services
Sun Pharma begins phase 2 trial on AQCH, a potential COVID-19 drug
The company received approval from Drugs Controller General of India for conducting the trials of phytopharmaceutical drug in April
Sensex takes a major hit over 1,500 pts on global equity rout
The rupee was trading flat at 73.89 against the US dollar in morning session
AstraZeneca to distribute Sun Pharma cancer medicines in China
Shares of Sun Pharma rose as much as 5.4 per cent to a nine-week high after the announcement.
Sebi orders forensic audit of Sun Pharma financial statements from FY16-18
Sun Pharma, however, did not provide any specific details on the reasons for the SEBI to order the forensic audit.
Sun Pharma, China Medical System Holdings enter into two license agreements
The initial tenure of the agreement shall be 15 years from the first commercial sale of CsA in Greater China.
Expect a volatile day in market
The Sensex rose 140 points or 0.36 per cent to close at 39,110, while the Nifty gained 29 points or 0.25 per cent to end at 11,738.
Sun Pharma's senior exec, wife settle insider trading case with Sebi
Gandhi and Kiran traded in 454 shares and 6,770 shares, respectively, during the UPSI period.
Short-term trend of Nifty looks weak
The Sensex closed 180 points or 0.46 per cent at 38,877, while the Nifty settled 69 points, or 0.59 per cent at 11,643.
Sun Pharma replaces domestic formulations distributor with its own subsidiary
The company also announced unwinding of a transaction amounting to Rs 2,238 crore with Atlas Global Trading.